Nolato AB
Sweden · SE0015962477 · reports in SEK · Europe
Four figures
From the annual report for the year to Dec 31, 2025. Each line says what it is based on.
- Revenue growth
- Revenue −2.1% in the year to Dec 31, 2025, on the year before.
- Return on equity
- It earned 14% on its shareholders' equity in the year to Dec 31, 2025.
- Equity and assets
- Equity is 60% of its assets, and operations brought in cash in the year.
- Price and earnings
- Not answered: no exchange publishes this company's price for free reuse, so there is no P/E here.
The year
Year to Dec 31, 2025, consolidated, in SEK.
revenue
operating margin
net profit
Year by year
As filed; an earlier year can differ from its own report when the company restated it.
| Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|
| Revenue | SEK 10.8B | SEK 9.5B | SEK 9.7B | SEK 9.5B |
| Operating profit | SEK 867M | SEK 657M | SEK 913M | SEK 1.0B |
| Net profit to shareholders | SEK 697M | SEK 435M | SEK 658M | SEK 777M |
| Dividend per share | n/a | n/a | n/a | SEK 1.50 |
| Cash from operations | SEK 406M | SEK 781M | SEK 1.4B | SEK 1.1B |
| Capital spending | SEK 451M | SEK 426M | SEK 635M | SEK 784M |
| Cash | SEK 1.0B | SEK 688M | SEK 672M | SEK 482M |
| Total assets | SEK 10.0B | SEK 9.3B | SEK 9.7B | SEK 9.3B |
| Equity | SEK 5.4B | SEK 5.2B | SEK 5.7B | SEK 5.5B |
What they do
In the company's own words, from the annual report.
Not 1 Allmän information Nolato är en högteknologisk utvecklare och tillverkare av po- lymera produktsystem till ledande kunder inom bland annat medicinteknik, läkemedel, konsumentelektronik, telekom, fordon, hygien och andra utvalda industriella sektorer.
Source: the company’s annual financial report in ESEF, via filings.xbrl.org (XBRL International). Listed shares from ESMA’s FIRDS register; ESMA does not endorse this site. Ryufin computed the ratios from the filed figures.